본문 바로가기
KERD
논문KCI 등재

Clostridium difficile에 의한 설사의 예후인자

Prognosis Factors of Clostridium difficile Associated Diarrhea

정수진|김명수|이경원|김희정|최준용|김영근|신소연|박윤선|최희경|김연아|김준형|구남수|송영구|김중명
대한감염학회 (The Korean Society Of Infectious Diseases)|2007.04|Infection and Chemotherapy|제39권 제2호|pp. 71-77

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류내과학

초록

배 경 : Clostridium difficile에 의한 설사(Clostridium difficile associated diarrhea; CDAD)는 임상 경과가 다양하다. 최근에 유럽과 북미에서 C. difficile 감염의 발생률이 증가하고 고전적 치료에 잘 반응하지 않으며 이환률이 증가하였고, 이러한 원인이 새로운 균주의 탄생에 기인한다고 보고되었다. CDAD의 예후에 영향을 미치는 세균성 요인과 숙주 요인을 확인하기 위해 본 연구를 진행하였다. 재로 및 방법 : 2002년 8월부터 2003년 12월까지 CDAD가 진단된 20세 이상인 환자들을 대상으로 후향적 Cohort 연구를 하였다. 세균성 요인을 확인하기 위해 cdt A, cdt B, tcd A, tcd A rep 그리고 tcd B 유전자(binary toxin)를 확인하였다. 설사가 치료 시작 후 11일 이상 지속되거나, 2달 이내에 재발하거나, 수술 혹은 다른 시술이 필요한 경우, 사망한 경우 예후가 좋지 않은 것으로 정의하였다. 결 과 : 총 115예에서 toxin을 생성하는 C. difficile가 동정되었으며, Toxin A와 toxin B 모두 양성인 균이 91예, toxin B만 양성인 균이 24예였다. Toxin A 생성 여부가 예후에 영향을 미치지 않았지만, 제산제를 사용한 환자에서 그렇지 않은 환자에 비해 toxin B만 양성인 균이 많이 동정되었다(P<0.05). 예후가 좋지 않은 경우는 39예(33.9 %)였고 76예(66.1%)에서 예후는 양호하였다. 단변량 분석에서 70세 이상의 고령, 남성, 증상 발현 후 사용한 항생제의 개수 사용, 증상 발현 후 carbapenem, aminoglycoside, glycopeptide 사용, 당뇨 및 뇌졸중 병력이 있는 경우, 그리고 높은 Charlson index가 불량한 예후 인자로 확인되었다. 그러나 독립적인 예후 인자를 조사했을 때에는 70세 이상의 고령(odds ratio=3.378, P=0.009), 증상 발현 후 carbapenem 사용(odds ratio 7.210, P<0.001)이 예후에 중요한 영향을 미치는 요소로 확인되었다. 결 론 : 70세 이상의 고령과 증상 발현 후 carbapenem 사용이 CDAD 독립적인 불량한 예후인자이다.

Abstract

Background : Clostridium difficile associated diarrhea (CDAD) has a wide range of clinical manifestations. The prognostic factors of CDAD are not fully understood. Materials and Methods : A retrospective cohort study of 115 patients with CDAD from Aug. 2002 to Dec. 2003 was conducted to evaluate prognostic factors of CDAD. Bacteriologic factors were determined by detecting the binary toxin gene, tcd A, tcd A rep and tcd B gene. Poor prognosis was defined as diarrhea more than 10 days even with classic treatment, recurrence, death, and moribund discharge. Results : Approximately 79% of isolated strains were toxin A+/B+ strains and 21% were toxin A-/B+ strains. There was no difference in prognosis between toxin A+ and toxin A- strains. 39 (33.9%) cases showed poor prognosis and 76 (66.1%) cases showed good prognosis. Univariate analyses revealed that the poor prognostic factors were old age over 70 years old, male, the number of antibiotics used after onset of symptom, the administration of carbapenems, aminoglycosides, glycopeptides after onset of symptom, history of DM and stroke, and high Charlson comorbidity index. Multiple logistic regression analysis identified old age over 70 years old (odds ratio=3.378, P=0.009) and the administration of carbapenems after onset of symptom (odds ratio 7.210, P<0.001) as the independent poor prognostic factors. Conclusion : Old age over 70 and the administration of carbapenems after onset of symptom were the poor prognostic factors for CDAD caused by none-binary toxin producing strains.

참고문헌 (34)

  1. Fekety R, "Diagnosis and treatment of Clostridium difficile colitis", 269, pp.71~5 (1993)
  2. McFarland LV, "Nosocomial acquisition of Clostridium difficile infection", 320, pp.204~10 (1989)
  3. Guerrant RL, "Diarrhea in developed and developing countries:magnitude,special settings,and etiologies", 1, pp.~50 (1990)
  4. Kelly CP, "Clostridium difficile colitis", 330, pp.257~62 (1994)
  5. Kyne L MA, "Hospital-acquired dairrhoea in elderly patients:epidemiology and staff awareness", 27, pp.339~343 (1998)
  6. Pothoulakis C, "Pathogenesis of Clostridium difficile- associated diarrhoea", 8, pp.1041~1047 (1996)
  7. Kyne L, "Factors associated with prolonged symptoms and severe disease due to Clostridium difficile", 28, pp.107~113 (1999)
  8. Rubin MS, "Severe Clostridium difficile colitis", 38, pp.350~354 (1995)
  9. Cheng SH, "Clostridium difficile-associated diseases:comparison of symptomatic infection versus carriage on the basis of risk factors,toxin production,and genotyping results", 25, pp.157~158 (1997)
  10. McFarland LV, "Correlation of immunoblot type,enterotoxin production,and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients", 59, pp.2456~62 (1991)
  11. Musher DM, "Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole", 40, pp.1586~1590 (2005)
  12. Pepin J, "Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity", 171, pp.466~472 (2004)
  13. Warny M, "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe", 366, pp.1079~1084 (2005)
  14. Gerding DN, "Clostridium difficile-associated disease, including pseudomembranous colitis", pp.760~762 (2005), McGrawHill
  15. Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies:development and validation", 40, pp.373~83 (1987)
  16. Morris JB, "Role of surgery in antibiotic-induced pseudomembranous enterocolitis", pp.535~9 (1990)
  17. Kyne L, "Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile", 34, pp.346~353 (2002)
  18. Layton BA ML, "Perceived increases in the incidence and severity of Clostridium difficile disease: an emerging threat that continues to unfold. In: Proceedings of 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Los Angeles, April 9-12, 2005" (2005)
  19. Dallal RM, "Fulminant Clostridium difficile:an underappreciated and increasing cause of death and complications", 235, pp.363~372 (2002)
  20. Popoff MR, "Actin- specific ADP-ribosyltransferase produced by a Clostridium difficile strain", 56, pp.2299~306 (1988)
  21. Barbut F, "Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France", 40, pp.2079~2083 (2002)
  22. Johnson S, "Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay", 135, pp.434~438 (2001)
  23. Limaye AP, "Pseudomembranous colitis caused by a toxin A (－) B (＋) strain of Clostridium difficile", 38, pp.1696~1697 (2000)
  24. Kato H, "Identification of toxin A-negative,toxin B-positive Clostridium difficile by PCR", 36, pp.2178~2182 (1998)
  25. Lyerly DM, "Multicenter evaluation of the Clostridium difficile TOX A", B TEST, 1998, pp.36, 184~190
  26. Alfa MJ, "Characterization of a toxin A-negative,toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea", 38, pp.2706~2714 (2000)
  27. Goncalves C, "Prevalence and characterization of a binary toxin(actin-specific ADP-ribosyltransferase)from Clostridium difficile", 42, pp.1933~1939 (2004)
  28. Rupnik M GM, "Binary toxin producing Clostridium difficile strains", 9, pp.289~294 (2003)
  29. Gulke I, "Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile", 69, pp.6004~6011 (2001)
  30. McDonald LC, "An epidemic,toxin gene-variant strain of Clostridium difficile", 353, pp.2433~2441 (2005)
  31. Do AN, "Risk factors for early recurrent Clostridium difficile- associated diarrhea", 26, pp.954~959 (1998)
  32. Fernandez A, "Factors associated with failure of metronidazole in Clostridium difficile-associated disease", 38, pp.414~418 (2004)
  33. Modena S, "Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea", 40, pp.49~54 (2006)
  34. Ramaswamy R, "Prognostic criteria in Clostridium"

관련 논문AI추천

투여 항생제군과 Clostridium Difficile-Associated Diarrhea의 위험인자 분석오경선, 이숙향한국임상약학회 · 한국임상약학회지2010 · 제20권 제1호Frequency of Clostridium difficile-associated Diarrhea and Relevant Medical Treatment in a Tertiary Care Hospital in Korea강혜경한국임상약학회 · 한국임상약학회지2011 · 제21권 제3호Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea강정옥, 김지은, 배현주, 서미란, 최태열대한감염학회 · Infection and Chemotherapy2013 · 제45권 제2호Clostridium difficile-associated disease에 사용되는 경구용 Vancomycin의 사용 실태 및 치료실패에 영향을 미치는 요인 분석김향숙, 이주연, 이혜숙, 조윤숙, 최유정한국병원약사회 · 병원약사회지2013 · 제30권 제3호Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated Diarrhea김원호, 김태일, 이경주, 이진하, 이현정, 장희원, 전영은, 정은석, 천재희, 홍성필, Chang Mo Moon, Jae Jun Park, Jae Kook Shin, Kyu Sik Jung, Sang Hoon Lee, Soung Min Jeon거트앤리버 소화기연관학회협의회 · Gut and Liver2010 · 제4권 제3호Clinical and Microbiological Risk Factors for Clinical and Microbiological Risk Factors for Severe Clostridioides difficile Infections김도균, 김영아, 김희정, 유창승, 정석훈대한임상미생물학회 · Annals of Clinical Microbiology2022 · 제25권 제1호

이 간행물의 다른 논문 (8건)

Piperacillin/Tazobactam 사용이 ESBL 생산균의 장집락에 미치는 영향서미란, 신현종, 안명주, 최태열, 이영열, 장윤숙, 배현주pp. 65-70A Quantitative Comparison of Vaccinia Virus Shedding from Conventional Dressing Sites and Vaccination Lesions after Smallpox Vaccination김홍빈, 지영미, 최강원, 조재현, 조해월, 김성한, 오명돈, 방지환, 김남중, 여상구pp. 78-84A Case of Subacute Infective EndocarditisCaused by Arcanobacterium haemolyticumin a Patient with Mitral Valve Prolapse이혜경, 박경수, 최수미, 신완식, 전희경, 박연준, 문석환, 김양리pp. 85-92국내 젊은 남성들의 Epstein-Barr 바이러스항체보유율최창민, 강철인, 박정탁, 박태성pp. 93-94사람면역결핍바이러스 모자 수직전파 예방 : 일개 대학병원의 경험김기형, 박수은, 곽임수, 조군제, 설영미, 이선희, 류은경pp. 95-99
원문 보기